Free tool
FAERS Monitor: Midamor
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018200 or its brand name (Midamor, Amiloride Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
858
Serious
731
85% of reports
Hospitalization
398
Death reported
63
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dyspnoea69
- diarrhoea58
- nausea49
- drug interaction41
- hyperkalaemia39
- vomiting39
- malaise38
- fatigue37
- fall36
- confusional state33
- headache32
- abdominal pain29
- off label use29
- pruritus29
- renal failure acute29
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 3 |
| 2005 | 6 |
| 2006 | 28 |
| 2007 | 68 |
| 2008 | 74 |
| 2009 | 75 |
| 2010 | 85 |
| 2011 | 78 |
| 2012 | 76 |
| 2013 | 13 |
| 2014 | 9 |
| 2015 | 18 |
| 2016 | 34 |
| 2017 | 9 |
| 2018 | 40 |
| 2019 | 36 |
| 2020 | 29 |
| 2021 | 20 |
| 2022 | 37 |
| 2023 | 34 |
| 2024 | 38 |
| 2025 | 26 |
| 2026 | 22 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,301 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| hyperkalaemiaSignal | 39 | 27.3 | 20.1 | 962 |
| renal failure acuteSignal | 29 | 16.8 | 11.7 | 415 |
| drug interactionSignal | 41 | 6.3 | 4.7 | 180 |
| confusional stateSignal | 33 | 5.0 | 3.6 | 103 |
| abdominal painSignal | 29 | 3.1 | 2.1 | 39 |
| dyspnoeaSignal | 69 | 3.0 | 2.4 | 92 |
| fallSignal | 36 | 2.7 | 1.9 | 36 |
| diarrhoeaSignal | 58 | 2.2 | 1.7 | 38 |
| malaiseSignal | 38 | 2.1 | 1.6 | 22 |
| vomitingSignal | 39 | 2.0 | 1.5 | 20 |
| pruritus | 29 | 1.8 | 1.3 | 11 |
| nausea | 49 | 1.5 | 1.2 | 8 |
| headache | 32 | 1.3 | 0.9 | 1 |
| fatigue | 37 | 1.2 | 0.9 | 1 |
| off label use | 29 | 0.8 | 0.6 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.